Circulating Tumor Microemboli Diagnostics for Patients with Non-Small Cell Lung Cancer

INTRODUCTION: Circulating Tumor Microemboli (CTM) are potentially important cancer biomarkers, but using them for cancer detection in early stage disease has been assay limited. We examined CTM test performance using a sensitive detection platform to identify stage I Non-Small Cell Lung Cancer (NSCL...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Carlsson, Anders, Nair, Viswam S., Luttgen, Madelyn S., Keu, Khun Visith, Horng, George, Vasanawala, Minal, Kolatkar, Anand, Jamali, Mehran, Iagaru, Andrei H., Kuschner, Ware, Loo, Billy W., Shrager, Joseph B., Bethel, Kelly, Hoh, Carl K., Bazhenova, Lyudmila, Nieva, Jorge, Kuhn, Peter, Gambhir, Sanjiv S.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2014
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4145608/
https://ncbi.nlm.nih.gov/pubmed/25157764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000235
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים